Dual role of HDAC10 in lysosomal exocytosis and DNA repair promotes neuroblastoma chemoresistance
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dual role of HDAC10 in lysosomal exocytosis and DNA repair promotes neuroblastoma chemoresistance
Authors
Keywords
-
Journal
Scientific Reports
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-06-27
DOI
10.1038/s41598-018-28265-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Marbostat-100 Defines a New Class of Potent and Selective Antiinflammatory and Antirheumatic Histone Deacetylase 6 Inhibitors
- (2018) Andreas Sellmer et al. JOURNAL OF MEDICINAL CHEMISTRY
- HDAC10 as a potential therapeutic target in ovarian cancer
- (2017) Muhtadi M. Islam et al. GYNECOLOGIC ONCOLOGY
- Histone deacetylase 10 structure and molecular function as a polyamine deacetylase
- (2017) Yang Hai et al. Nature Communications
- Lysosomal accumulation of anticancer drugs triggers lysosomal exocytosis
- (2017) Benny Zhitomirsky et al. Oncotarget
- Analysis of the interplay between all-trans retinoic acid and histone deacetylase inhibitors in leukemic cells
- (2016) Katrin Noack et al. ARCHIVES OF TOXICOLOGY
- Inhibitors of histone deacetylase as antitumor agents: A critical review
- (2016) Mohammed Manal et al. BIOORGANIC CHEMISTRY
- Role of autophagy and lysosomal drug sequestration in acquired resistance to doxorubicin in MCF-7 cells
- (2016) Baoqing Guo et al. BMC CANCER
- Inhibition of histone deacetylases in cancer therapy: lessons from leukaemia
- (2016) Elena Ceccacci et al. BRITISH JOURNAL OF CANCER
- An ER-Associated Pathway Defines Endosomal Architecture for Controlled Cargo Transport
- (2016) Marlieke L.M. Jongsma et al. CELL
- Lysosomes as mediators of drug resistance in cancer
- (2016) Benny Zhitomirsky et al. DRUG RESISTANCE UPDATES
- The position of lysosomes within the cell determines their luminal pH
- (2016) Danielle E. Johnson et al. JOURNAL OF CELL BIOLOGY
- A mechanism for overcoming P-glycoprotein-mediated drug resistance: novel combination therapy that releases stored doxorubicin from lysosomes via lysosomal permeabilization using Dp44mT or DpC
- (2016) Nicole A Seebacher et al. Cell Death & Disease
- SGO1 is involved in the DNA damage response in MYCN-amplified neuroblastoma cells
- (2016) Yuko Murakami-Tonami et al. Scientific Reports
- Vacuolar-ATPase-mediated intracellular sequestration of ellipticine contributes to drug resistance in neuroblastoma cells
- (2015) JAN HRABETA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Histone Deacetylase 10 Regulates DNA Mismatch Repair and May Involve the Deacetylation of MutS Homolog 2
- (2015) Rangasudhagar Radhakrishnan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Neuroblastoma: oncogenic mechanisms and therapeutic exploitation of necroptosis
- (2015) S Nicolai et al. Cell Death & Disease
- Regulated lysosomal exocytosis mediates cancer progression
- (2015) E. Machado et al. Science Advances
- HDAC Family Members Intertwined in the Regulation of Autophagy: A Druggable Vulnerability in Aggressive Tumor Entities
- (2015) Emily Koeneke et al. Cells
- Lysosomal sequestration of hydrophobic weak base chemotherapeutics triggers lysosomal biogenesis and lysosome-dependent cancer multidrug resistance
- (2015) Benny Zhitomirsky et al. Oncotarget
- Cysteine cathepsins and extracellular matrix degradation
- (2014) Marko Fonović et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Phase 1 study of oral abexinostat, a histone deacetylase inhibitor, in combination with doxorubicin in patients with metastatic sarcoma
- (2014) Edwin Choy et al. CANCER
- ALK Mutations Confer Differential Oncogenic Activation and Sensitivity to ALK Inhibition Therapy in Neuroblastoma
- (2014) Scott C. Bresler et al. CANCER CELL
- Mechanisms of neuroblastoma regression
- (2014) Garrett M. Brodeur et al. Nature Reviews Clinical Oncology
- Histone deacetylase 10-promoted autophagy as a druggable point of interference to improve the treatment response of advanced neuroblastomas
- (2013) Ina Oehme et al. Autophagy
- Doxorubicin, DNA torsion, and chromatin dynamics
- (2013) Fan Yang et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- P-glycoprotein Mediates Drug Resistance via a Novel Mechanism Involving Lysosomal Sequestration
- (2013) Tetsuo Yamagishi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Histone deacetylase 10 promotes autophagy-mediated cell survival
- (2013) I. Oehme et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- GDC-0941 enhances the lysosomal compartment via TFEB and primes glioblastoma cells to lysosomal membrane permeabilization and cell death
- (2012) Stefanie Enzenmüller et al. CANCER LETTERS
- Phase I/II Intra-patient Dose Escalation Study of Vorinostat in Children with Relapsed Solid Tumor, Lymphoma or Leukemia
- (2012) O. Witt et al. KLINISCHE PADIATRIE
- Evaluation of Different Biomarkers to Predict Individual Radiosensitivity in an Inter-Laboratory Comparison–Lessons for Future Studies
- (2012) Burkhard Greve et al. PLoS One
- Involvement of Lysosomal Exocytosis in the Excretion of Mesoporous Silica Nanoparticles and Enhancement of the Drug Delivery Effect by Exocytosis Inhibition
- (2012) Rolando E. Yanes et al. Small
- Imidazoacridinone-dependent lysosomal photodestruction: a pharmacological Trojan horse approach to eradicate multidrug-resistant cancers
- (2012) Y Adar et al. Cell Death & Disease
- Polyamine pathway inhibition as a novel therapeutic approach to treating neuroblastoma
- (2012) Laura D. Gamble et al. Frontiers in Oncology
- Histone Deacetylases 9 and 10 Are Required for Homologous Recombination
- (2011) Shweta Kotian et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes
- (2011) Marcus Bantscheff et al. NATURE BIOTECHNOLOGY
- Pretreatment Mitochondrial Priming Correlates with Clinical Response to Cytotoxic Chemotherapy
- (2011) T. N. Chonghaile et al. SCIENCE
- Histone deacetylase inhibitor (HDACI) PCI-24781 potentiates cytotoxic effects of doxorubicin in bone sarcoma cells
- (2010) Cao Yang et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Combating apoptosis and multidrug resistant cancers by targeting lysosomes
- (2010) Line Groth-Pedersen et al. CANCER LETTERS
- HDAC6 controls autophagosome maturation essential for ubiquitin-selective quality-control autophagy
- (2010) Joo-Yong Lee et al. EMBO JOURNAL
- Rational Design and Simple Chemistry Yield a Superior, Neuroprotective HDAC6 Inhibitor, Tubastatin A
- (2010) Kyle V. Butler et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Reversal of P-glycoprotein-Mediated Multidrug Resistance by the Murine Double Minute 2 Antagonist Nutlin-3
- (2009) M. Michaelis et al. CANCER RESEARCH
- Disrupting Polyamine Homeostasis as a Therapeutic Strategy for Neuroblastoma
- (2009) N. F. Evageliou et al. CLINICAL CANCER RESEARCH
- Induction of autophagy by spermidine promotes longevity
- (2009) Tobias Eisenberg et al. NATURE CELL BIOLOGY
- Class II histone deacetylases play pivotal roles in heat shock protein 90-mediated proteasomal degradation of vascular endothelial growth factor receptors
- (2008) Jung-Hyun Park et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- HDAC family: What are the cancer relevant targets?
- (2008) Olaf Witt et al. CANCER LETTERS
- ODC1 Is a Critical Determinant of MYCN Oncogenesis and a Therapeutic Target in Neuroblastoma
- (2008) M. D. Hogarty et al. CANCER RESEARCH
- Histone Deacetylase 8 in Neuroblastoma Tumorigenesis
- (2008) I. Oehme et al. CLINICAL CANCER RESEARCH
- Tumor resistance to apoptosis
- (2008) Simone Fulda INTERNATIONAL JOURNAL OF CANCER
- The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men
- (2008) Xiang-Jiao Yang et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started